YixingJiangMDPh.D.

Oncology • Baltimore, MD

Associate Professor, Medicine, University of Maryland School of Medicine

Join to view full profile

Dr. Jiang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Jiang's full profile

Already have an account?

Office
22 S Greene St
Baltimore, MD 21201
Phone+1 410-328-6841

Fax+1 410-328-6896
Is this information wrong?

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2002 - 2005
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1999 - 2002
Shanghai Medical UniversityClass of 1990

Certifications & Licensure

MD State Medical License 2012 - 2024
PA State Medical License 2005 - 2024
TX State Medical License 2003 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer Start of enrollment: 2007 Dec 01
Completed
Phase 1
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2012 May 15
Active, not recruiting
Phase 2
Borderline Pancreas Study: FOLFIRINOX +SBRT Start of enrollment: 2014 Mar 01
Completed
Early Phase 1
1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2019 Dec 12
Recruiting
Phase 2
Futibatinib in Patients With Specific FGFR Aberrations Start of enrollment: 2020 Aug 24
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.
Allison M Kirk, Jeremy Chase Crawford, Ching-Heng Chou, Cliff Guy, Kirti Pandey, Tanya Kozlik, Ravi K Shah, Shanzou Chung, Phuong Nguyen, Xiaoyu Zhang, Jin Wang, Matth...> ;Cell Reports. Medicine. 2024 Mar 19
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Emiloju, O., Yin, J., Koubek, E., Reid, J., Borad, M., Lou, Y., Seetharam, M., Edelman, M., Sausville, E., Jiang, Y., Kaseb, A., Posey, J., Davis, S., Gores, G., Rober...> ;Investigational New Drugs. 2024 Feb 1
VetLLM: Large Language Model for Predicting Diagnosis from Veterinary Notes.
Irvin, J., Ng, A., Zou, J., Jiang, Y.> ;Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing. 2024 Jan 1
4 citations
A phase I study of the ceramide nanoliposome in patients with advanced solid tumors.
Aaron Ciner, Theodore Gourdin, Jeff Davidson, Mylisa Parette, Susan J Walker, Todd E Fox, Yixing Jiang> ;Cancer Chemotherapy and Pharmacology. 2024 Jan 1
1 citations
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies.
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang, Nariman Nezami> ;Cancers. 2023 May 5
Probabilistic Prediction of Laboratory Test Information Yield.
Lee, A., Ni, X., Corbin, C., Irvin, J., Ng, A., Chen, J., Jiang, Y.> ;AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2023 Jan 1
2 citations
BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities.
Aaron Tzvi Ciner, Yixing Jiang, Petr Hausner> ;Molecular Cancer Research. 2023 Apr 1
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and Guidelines.
Rachit Kumar, Leila Tchelebi, Christopher J Anker, Navesh Sharma, Nancy A Bianchi, Jadranka Dragovic, Karyn A Goodman, Joseph M Herman, Yixing Jiang, William E Jones 3...> ;American Journal of Clinical Oncology. 2022 Sep 1
Radiation Therapy and Malignant Fistulae of Anorectal Cancers.
Antony I Koroulakis, Jason K Molitoris, Michael Sullivan, Yixing Jiang, Petr F Hausner, Nader Hanna, Andrea Bafford, Robert C Miller, William F Regine> ;Practical Radiation Oncology. 2022 Jun 17
10 citations
Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience.
Antony Koroulakis, Jason K. Molitoris, Adeel Kaiser, Nader Hanna, Andrea C Bafford, Yixing Jiang, Søren M. Bentzen, William F. Regine> ;Advances in Radiation Oncology. 2021 Jan 1
25 citations
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical T...
Ross A. Abrams, Kathryn Winter, Howard Safran, Karyn A. Goodman, William F. Regine, Adam C. Berger, Michael Gillin, Philip A. Philip, Andrew M. Lowy, Abraham J. Wu, Th...> ;American Journal of Clinical Oncology. 2020 Mar 1
16 citations
Calcium: magnesium intake ratio and colorectal carcinogenesis, results from the prostate, lung, colorectal, and ovarian cancer screening trial.
Jing Zhao, Ayush Giri, Xiangzhu Zhu, Martha J. Shrubsole, Yixing Jiang, Xingyi Guo, Reid M. Ness, Douglas L. Seidner, Edward Giovannucci, Todd L. Edwards, Qi Dai> ;British Journal of Cancer. 2019 Sep 23
28 citations
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard Joseph Appleman, Jan H. Beumer, Yixing Jiang, Yan Lin, Fei Ding, Shannon Puhalla, Leigh Swartz, Taofeek K. Owonikoko, R. Donald Harvey, Ronald G. Stoller, Dani...> ;Cancer Chemotherapy and Pharmacology. 2019 Dec 1
15 citations
Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells.
Long Wu, Huan Zhang, Yixing Jiang, Robert C. Gallo, Hua Cheng> ;Proceedings of the National Academy of Sciences of the United States of America. 2018 May 8
11 citations
A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma.
Anthony B. El-Khoueiry, Robert T. O'Donnell, Thomas J. Semrad, Philip C. Mack, Suzette Blanchard, Nathan Bahary, Yixing Jiang, Yun Yen, John J. Wright, Helen X. Chen, ...> ;Cancer Chemotherapy and Pharmacology. 2018 Mar 8
53 citations
The use of nanoparticulates to treat breast cancer.
Xiaomeng Tang, Welley Siu Loc, Cheng Dong, Gail L. Matters, Peter J. Butler, Mark Kester, Craig Meyers, Yixing Jiang, James H. Adair> ;Nanomedicine. 2017 Sep 4
11 citations
Phase I study of veliparib in combination with gemcitabine.
Ronald G. Stoller, John C. Schmitz, Fei Ding, Shannon Puhalla, Chandra P. Belani, Leonard Joseph Appleman, Yan Lin, Yixing Jiang, Salah Almokadem, Daniel P. Petro, Jul...> ;Cancer Chemotherapy and Pharmacology. 2017 Aug 2
Structural evolution and mechanical behaviour of Pt nanoparticle superlattices at high pressure.
Zhu, J.,Quan, Z.,Wang, C.,Wen, X.,Jiang, Y.,Fang, J.,Wang, Z.,Zhao, Y.,Xu, H.> ;Nanoscale. 2016 Feb 18
16 citations
Advances in the Pharmacologic Treatment of Hepatocellular Carcinoma.
Neil H. Bhayani, Yixing Jiang, Osama Hamed, Eric T. Kimchi, Niraj J. Gusani> ;Current Clinical Pharmacology. 2015 Oct 31
5 citations
A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent
Leonard Joseph Appleman, Sanjeeve Balasubramaniam, Robert A. Parise, Christine Bryla, Christophe E. Redon, Asako J. Nakamura, William M. Bonner, John Wright, Richard P...> ;Clinical Cancer Research. 2015 Feb 15
6 citations
Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer "The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Loc...
Bora Lim, Yixing Jiang> ;Current Clinical Pharmacology. 2015 Oct 31
9 citations
Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer.
Yixing Jiang, Heath B. Mackley, Eric T. Kimchi, Junjia Zhu, Niraj J. Gusani, Jussuf T. Kaifi, Chandra P. Belani> ;Cancer Chemotherapy and Pharmacology. 2014 Jun 8
5 citations
Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis
Srinevas K. Reddy, Colleen Reilly, Min Zhan, Ayse L. Mindikoglu, Yixing Jiang, Barton F. Lane, H. Richard Alexander, William J. Culpepper, Samer S. El-Kamary> ;Medical Oncology. 2014 May 6
36 citations
Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer
Yixing Jiang, Nicole A. DiVittore, Megan M. Young, Zhiliang Jia, Keping Xie, Timothy M. Ritty, Mark Kester, Todd E. Fox> ;Biomolecules. 2013 Jul 25
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications.
Raad, I. I.,Chaftari, A. M.,Al Shuaibi, M. M.,Jiang, Y.,Shomali, W.,Cortes, J. E.,Lichtiger, B.,Hachem, R. Y.> ;Ann. Oncol.. 2013 Jul
Join now to see all